Bachem Holding AG, a leading global player in the biotechnology sector, is headquartered in Switzerland (CH) and operates extensively across Europe, North America, and Asia. Founded in 1971, Bachem has established itself as a pioneer in the development and production of peptide-based active pharmaceutical ingredients (APIs) and innovative drug delivery systems. The company’s core offerings include high-quality peptides and complex organic molecules, which are distinguished by their exceptional purity and reliability. Bachem's commitment to quality and sustainability has earned it a prominent position in the pharmaceutical and biotech industries, with notable achievements in custom synthesis and contract manufacturing. As a trusted partner for major pharmaceutical companies, Bachem continues to drive advancements in therapeutic solutions, solidifying its reputation as a leader in peptide chemistry.
How does Bachem Holding AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Bachem Holding AG's score of 18 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Bachem Holding AG, headquartered in Switzerland, is committed to addressing climate change through various initiatives, although specific carbon emissions data is currently unavailable. The company has made a commitment to near-term science-based targets, indicating a proactive approach to reducing its carbon footprint. As part of the pharmaceuticals, biotechnology, and life sciences sector, Bachem is focused on aligning its operations with industry standards for sustainability. While the company has not set a net-zero target, it is actively engaged in climate commitments, as evidenced by its participation in the Science Based Targets initiative (SBTi). Bachem's climate strategy reflects a commitment to transparency and accountability in its environmental impact, although further details on specific reduction targets or achievements are not provided at this time. The absence of emissions data suggests that the company may still be in the process of establishing comprehensive reporting mechanisms. Overall, Bachem Holding AG is taking steps towards climate responsibility, with a focus on future emissions reduction and sustainability within its operational framework.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Bachem Holding AG has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
